\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ stable\\ from\\ previous\\ visits\\.\\ no\\ tenderness\\ to\\ palpation\\ within\\ the\\ examined\\ musculoskeletal\\ system\\.\ \(0\)\
\-\ laboratory\\ \\-\\ \ \(0\)\
\-\ psa\\ from\\ may\\ 7\\ \\-\\ 603\\.\ \(0\)\
\-\ psa\\ from\\ june\\ 13\\ \\-\\ 4622\\.\ \(0\)\
\-\ while\\ giving\\ results\\ of\\ the\\ study\\ to\\ physician\\,\\ he\\ relays\\ that\\ the\\ patient\\ will\\ undergo\\ chemotherapy\\ for\\ his\\ disease\\.\\ \\ the\\ patient\\ reports\\ no\\ bone\\ pain\\ presently\\,\\ but\\ it\\ is\\ likely\\ that\\ at\\ some\\ point\\ during\\ his\\ chemotherapy\\ he\\ will\\ experience\\ some\\ pain\\.\\ \\ accordingly\\,\\ samarium\\-153\\ therapy\\ is\\ indicated\\ in\\ the\\ treatment\\ of\\ this\\ patient\\ if\\ bony\\ pain\\ were\\ to\\ occur\\,\\ given\\ the\\ bone\\ scan\\ activity\\ of\\ the\\ metastatic\\ lesions\\.\\ \\ disease\\ progression\\/remission\\ can\\ be\\ monitored\\ with\\ further\\ bone\\ scans\\.\\ \\ plain\\ films\\ are\\ recommended\\ for\\ evaluation\\ of\\ the\\ large\\ joints\\ and\\ spine\\ if\\ to\\ evaluate\\ for\\ pathologic\\ fractures\\,\\ and\\ weight\\ bearing\\ joints\\ should\\ be\\ evaluated\\ for\\ possible\\ xrt\\.\ \(0\)\
\-\ rapid\\ interval\\ progression\\ of\\ the\\ patient\\'s\\ metastatic\\ prostate\\ cancer\\.\ \(0\)\
\-\ metastatic\\ prostate\\ cancer\ \(4\)\
\-\ metastatic\\ prostate\\ cancer\\ \\(given\\ known\\ history\\)\ \(0\)\
\-\ other\\ metastatic\\ neoplasm\\ \\(renal\\,\\ lung\\,\\ breast\\,\\ etc\\.\\)\ \(0\)\
\-\ patient\\ with\\ known\\ prostate\\ cancer\\ with\\ rise\\ in\\ psa\\ from\\ 600\\ to\\ 4600\\ in\\ one\\ month\\'s\\ time\\.\\ \\ patient\\ non\\-symptomatic\\.\ \(0\)\
\-\ see\\ treatment\\ and\\ followup\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ prostate\\:\\ 0\\.08728562124904699\ \(0\)\
\-\ psa\\:\\ 0\\.08628324634485984\ \(0\)\
\-\ cancer\\:\\ 0\\.054022408930091644\ \(0\)\
\-\ metastatic\\:\\ 0\\.051709360663848326\ \(0\)\
\-\ 603\\.\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ 4622\\.\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ relays\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ progression\\/remission\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ 4600\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ non\\-symptomatic\\:\\ 0\\.04238230011522355\ \(0\)\
\-\ samarium\\-153\\:\\ 0\\.03904986174714689\ \(0\)\
\-\ joints\\:\\ 0\\.03759849659161605\ \(0\)\
\-\ accordingly\\:\\ 0\\.03464461784390576\ \(0\)\
\-\ 600\\:\\ 0\\.03302696286014993\ \(0\)\
\-\ presently\\:\\ 0\\.031818720416491725\ \(0\)\
\-\ bone\\:\\ 0\\.030626461751825047\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.02945140178020063\ \(0\)\
\-\ visits\\:\\ 0\\.029362827994539847\ \(0\)\
\-\ given\\:\\ 0\\.028167446081887912\ \(0\)\
\-\ xrt\\:\\ 0\\.027979741107752438\ \(0\)\
\-\ june\\:\\ 0\\.02690693557258797\ \(0\)\
\-\ giving\\:\\ 0\\.02690693557258797\ \(0\)\
\-\ rise\\:\\ 0\\.026536930567125815\ \(0\)\
\-\ \\-\\:\\ 0\\.02641916046213986\ \(0\)\
\-\ known\\:\\ 0\\.0260004911967675\ \(0\)\
\-\ examined\\:\\ 0\\.0258727462475065\ \(0\)\
\-\ will\\:\\ 0\\.025706548253645597\ \(0\)\
\-\ some\\:\\ 0\\.0249512332102573\ \(0\)\
\-\ monitored\\:\\ 0\\.02476902297036948\ \(0\)\
\-\ patient\\:\\ 0\\.024709382622588115\ \(0\)\
\-\ from\\:\\ 0\\.024354532945273316\ \(0\)\
\-\ bearing\\:\\ 0\\.023770756793551\ \(0\)\
\-\ his\\:\\ 0\\.023681625265835886\ \(0\)\
\-\ he\\:\\ 0\\.022924878288779035\ \(0\)\
\-\ experience\\:\\ 0\\.02254030787942984\ \(0\)\
\-\ if\\:\\ 0\\.02229560994019842\ \(0\)\
\-\ etc\\:\\ 0\\.0222397292400965\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.021498620202465454\ \(0\)\
\-\ undergo\\:\\ 0\\.020856642353309095\ \(0\)\
\-\ rapid\\:\\ 0\\.020748599777097275\ \(0\)\
\-\ progression\\:\\ 0\\.02043831842547434\ \(0\)\
\-\ interval\\:\\ 0\\.020146853897510707\ \(0\)\
\-\ followup\\:\\ 0\\.019612115267173092\ \(0\)\
\-\ physician\\:\\ 0\\.01936551289030987\ \(0\)\
\-\ scans\\:\\ 0\\.019130944793341445\ \(0\)\
\-\ evaluated\\:\\ 0\\.018834993384690323\ \(0\)\
\-\ 13\\:\\ 0\\.018556208492140566\ \(0\)\
\-\ \\'s\\:\\ 0\\.018115832868913894\ \(0\)\
\-\ pathologic\\:\\ 0\\.01798242600352246\ \(0\)\
\-\ point\\:\\ 0\\.01795247143741363\ \(0\)\
\-\ indicated\\:\\ 0\\.01777656063245069\ \(0\)\
\-\ recommended\\:\\ 0\\.01703134069905169\ \(0\)\
\-\ films\\:\\ 0\\.016957939390730592\ \(0\)\
\-\ stable\\:\\ 0\\.01693371922712503\ \(0\)\
\-\ treatment\\:\\ 0\\.016630932303854682\ \(0\)\
\-\ evaluate\\:\\ 0\\.016606857010851312\ \(0\)\
\-\ results\\:\\ 0\\.016584338504541572\ \(0\)\
\-\ reports\\:\\ 0\\.0165619249799944\ \(0\)\
\-\ bony\\:\\ 0\\.016429594819465123\ \(0\)\
\-\ system\\:\\ 0\\.01617538447308076\ \(0\)\
\-\ previous\\:\\ 0\\.015953606724390848\ \(0\)\
\-\ 7\\:\\ 0\\.015741609994269577\ \(0\)\
\-\ fractures\\:\\ 0\\.01555667595182825\ \(0\)\
\-\ occur\\:\\ 0\\.015413685715295859\ \(0\)\
\-\ activity\\:\\ 0\\.015413685715295859\ \(0\)\
\-\ breast\\:\\ 0\\.015156528576108426\ \(0\)\
\-\ laboratory\\:\\ 0\\.01513986411468301\ \(0\)\
\-\ pain\\:\\ 0\\.015052040877847136\ \(0\)\
\-\ weight\\:\\ 0\\.014725700890100314\ \(0\)\
\-\ that\\:\\ 0\\.014192122389988687\ \(0\)\
\-\ for\\:\\ 0\\.014021310550821446\ \(0\)\
\-\ neoplasm\\:\\ 0\\.013991137384191964\ \(0\)\
\-\ possible\\:\\ 0\\.013836452975404194\ \(0\)\
\-\ palpation\\:\\ 0\\.013711245578596404\ \(0\)\
\-\ spine\\:\\ 0\\.013529343971179558\ \(0\)\
\-\ study\\:\\ 0\\.013517458446442112\ \(0\)\
\-\ disease\\:\\ 0\\.013430168665535617\ \(0\)\
\-\ plain\\:\\ 0\\.013342614003312906\ \(0\)\
\-\ should\\:\\ 0\\.013097156451388462\ \(0\)\
\-\ further\\:\\ 0\\.013064635297116626\ \(0\)\
\-\ while\\:\\ 0\\.012926198268520738\ \(0\)\
\-\ be\\:\\ 0\\.012670737724460857\ \(0\)\
\-\ during\\:\\ 0\\.012572159855402923\ \(0\)\
\-\ tenderness\\:\\ 0\\.012494770783084776\ \(0\)\
\-\ renal\\:\\ 0\\.01234363244931764\ \(0\)\
\-\ month\\:\\ 0\\.012325069907695238\ \(0\)\
\-\ see\\:\\ 0\\.012260659669369175\ \(0\)\
\-\ evaluation\\:\\ 0\\.011933840364551961\ \(0\)\
\-\ lung\\:\\ 0\\.01189980346268628\ \(0\)\
\-\ time\\:\\ 0\\.011603852054035158\ \(0\)\
\-\ likely\\:\\ 0\\.01158793252853681\ \(0\)\
\-\ scan\\:\\ 0\\.011501305098235473\ \(0\)\
\-\ one\\:\\ 0\\.01113332395822425\ \(0\)\
\-\ lesions\\:\\ 0\\.010997887049730518\ \(0\)\
\-\ therapy\\:\\ 0\\.010983849981926025\ \(0\)\
\-\ \\,\\:\\ 0\\.010411925596818746\ \(0\)\
\-\ to\\:\\ 0\\.010266060299110247\ \(0\)\
\-\ physical\\:\\ 0\\.010079352257602108\ \(0\)\
\-\ other\\:\\ 0\\.009469416099531003\ \(0\)\
\-\ were\\:\\ 0\\.009328299695624622\ \(0\)\
\-\ can\\:\\ 0\\.009318376694562836\ \(0\)\
\-\ it\\:\\ 0\\.00923484800256258\ \(0\)\
\-\ exam\\:\\ 0\\.009025163172834319\ \(0\)\
\-\ may\\:\\ 0\\.009011194081240981\ \(0\)\
\-\ large\\:\\ 0\\.00898337707611096\ \(0\)\
\-\ but\\:\\ 0\\.008762035101122778\ \(0\)\
\-\ no\\:\\ 0\\.00827350144907502\ \(0\)\
\-\ within\\:\\ 0\\.007837170232625392\ \(0\)\
\-\ \\(\\:\\ 0\\.00694578582926789\ \(0\)\
\-\ \\)\\:\\ 0\\.006860939347243318\ \(0\)\
\-\ in\\:\\ 0\\.006077844665484447\ \(0\)\
\-\ the\\:\\ 0\\.00598194020352227\ \(0\)\
\-\ history\\:\\ 0\\.005674108354360978\ \(0\)\
\-\ are\\:\\ 0\\.005600355156392316\ \(0\)\
\-\ at\\:\\ 0\\.005566169003998236\ \(0\)\
\-\ is\\:\\ 0\\.0054066420998531315\ \(0\)\
\-\ this\\:\\ 0\\.004620851987087178\ \(0\)\
\-\ of\\:\\ 0\\.0028005721345670297\ \(0\)\
\-\ and\\:\\ 0\\.0025962837365223817\ \(0\)\
\-\ \\.\\:\\ 0\\.002048050159462285\ \(0\)\
\-\ with\\:\\ 0\\.0016875602320657174\ \(0\)\
